Tat and amyloid: Multiple interactions.
Prolonged treatment interruption in chronic HIV infection: a new strategy?.

Emergence of HIV-1 CRF01_AE/B unique recombinant forms in Kuala Lumpur, Malaysia.
HIV-1 Tat inhibits neprilysin and elevates amyloid [beta].
Hydroxyurea exerts a cytostatic but not immunosuppressive effect on T lymphocytes.


Registration of clinical trials.
Tat and amyloid: Multiple interactions.
HAART, viral load and sexual risk behaviour

HIV infection and the gastrointestinal tract.
Identifying deaths from AIDS in South Africa.

Prolonged treatment interruption in chronic HIV infection: a new strategy?.
Impact of African herbal medicines on antiretroviral metabolism.
